Barclays PLC (BCS)
After hours:
| Previous Close | 11.75 |
| Open | 11.89 |
| Bid | 11.97 x 4000 |
| Ask | 11.98 x 3200 |
| Day's Range | 11.85 - 12.01 |
| 52 Week Range | 6.23 - 12.12 |
| Volume | |
| Avg. Volume | 11,229,840 |
| Market Cap | 44.119B |
| Beta (5Y Monthly) | 1.39 |
| PE Ratio (TTM) | 8.94 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.35 (2.89%) |
| Ex-Dividend Date | Feb 29, 2024 |
| 1y Target Est | N/A |
- Business Wire
Barclays Bank PLC Amends Purchase Price of Certain Cash Tender Offers and Consent Solicitations
NEW YORK, July 16, 2024--Barclays Bank PLC (the "Issuer") announced today that, in connection with its previously announced cash tender offers (each, an "Offer") to purchase any and all of its outstanding exchange-traded notes (the "Notes" or the "ETNs") of six separate series (each, a "Series") and the solicitation of consents (each, a "Consent Solicitation") from holders of the Notes (the "Noteholders") to amend certain provisions of the Notes with respect to each Series, it has amended the Pu
- Business Wire
Barclays Announces a Reverse Split of the iPath® Series B S&P 500® VIX Short-Term Futures™ ETNs and the iPath® Series B S&P 500® VIX Mid-Term Futures™ ETNs
NEW YORK, July 10, 2024--Barclays Bank PLC ("Barclays") announced today that it will implement a 1 for 4 reverse split of two series of iPath® ETNs (together, the "ETNs"): the iPath® Series B S&P 500® VIX Short-Term Futures™ ETNs (CUSIP: 06748F324) (the "VXX ETNs") and the iPath® Series B S&P 500® VIX Mid-Term Futures™ ETNs (CUSIP: 06746P613) (the "VXZ ETNs"). Barclays intends the reverse split for each series of ETNs to be effective at the open of trading on Wednesday, July 24, 2024. Each serie
- Business Wire
Barclays US LLC Annual Stress Test Results
NEW YORK, June 28, 2024--Barclays PLC notes the Federal Reserve Board’s ("FRB") publication of the results from its annual bank stress tests on 26 June 2024. The projected capital ratios for Barclays US LLC (Barclays’ US intermediate holding company) remained above the regulatory minimum required levels across all nine quarters of the test.
